Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is ...

Earlier this month, venture capitalist and OpenAI backer Geoff Lewis posted an alarming video on X-formerly-Twitter, ...

As AI gets more curious, security gaps widen. Explore the risks of prompt exfiltration and autonomous model behavior.

AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI's impact in ...

Discover how self-improving AI systems are redefining innovation, reshaping industries, and challenging our understanding of ...

Reality is increasingly under attack by AI. Deepfakes now threaten identity, trust, and enterprise security which is why ...

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence company transforming oncology drug discovery and development, today announced the public release of its AI module for ...

Professor David Meyer (CivMin) and CivMin PhD student Omar Abdelazeem synthesized best practices to create the SWMMIN model ...

Whether for AI training hubs or latency-sensitive inference applications, these locations are becoming critical to keeping ...

Is ordering your study notes as overwhelming as cracking a cryptic crossword? Google’s new AI Mode update hopes to bring that disorganisation into shape, combining real-time visual help and ...

Blockstream has announced the public release of Simplicity, a purpose-built smart contracting language now live on the Liquid ...

Artificial intelligence is advancing at a speed that’s difficult to comprehend. To describe this phenomenon, insiders have begun referencing what some call “OpenAI’s Law”—a modern parallel to Moore’s ...